Denali Therapeutics, Inc. (DNLI)

20.57 -0.14 (-0.68%) USD  |  NASDAQ  |  Apr 17, 16:00
20.57 0.00 (0.00%) After-Hours: 04:07
More

Denali Therapeutics Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
Neurocrine Biosciences, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Biogen, Inc. Upgrade
Agenus, Inc. Upgrade
Curis, Inc. Upgrade